zoledronic acid has been researched along with Cholangiocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borghetti, AF; Desenzani, S; La Monica, S; Morganti, MM; Romani, AA; Soliani, P | 1 |
| Baroni, MC; Borghetti, AF; Desenzani, S; Morganti, MM; Romani, AA; Soliani, P | 1 |
2 other study(ies) available for zoledronic acid and Cholangiocarcinoma
| Article | Year |
|---|---|
Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Diphosphonates; Humans; Imidazoles; S Phase; Zoledronic Acid | 2009 |
The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.
Topics: Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biphenyl Compounds; Cell Line, Tumor; Cholangiocarcinoma; Diphosphonates; Drug Delivery Systems; Drug Synergism; Gene Expression Regulation; Humans; Imidazoles; Nitrophenols; Piperazines; S Phase; Sulfonamides; Zoledronic Acid | 2011 |